These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

944 related items for PubMed ID: 25882035

  • 21. Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis.
    Back K, Choe JH, Kim JS, Kim JH.
    Eur J Surg Oncol; 2021 Jun; 47(6):1339-1345. PubMed ID: 33744024
    [Abstract] [Full Text] [Related]

  • 22. [Prospective analysis of the risk factors and clinical indications of dissection of lymph node posterior to right recurrent laryngeal nerve in 283 cases of papillary thyroid carcinoma].
    Zhang P, Zhang B, Bu J, Liu Y, Zhang W.
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):109-14. PubMed ID: 24796458
    [Abstract] [Full Text] [Related]

  • 23. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC, Na SY, Park GC, Han JH, Kim SW, Eun YG.
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [Abstract] [Full Text] [Related]

  • 24. Can Unilateral Therapeutic Central Lymph Node Dissection Be Performed in Papillary Thyroid Cancer with Lateral Neck Metastasis?
    Cetinoglu I, Aygun N, Yanar C, Caliskan O, Kostek M, Unlu MT, Uludag M.
    Sisli Etfal Hastan Tip Bul; 2023 Feb; 57(4):458-465. PubMed ID: 38268664
    [Abstract] [Full Text] [Related]

  • 25. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma.
    Zhang L, Liu H, Xie Y, Xia Y, Zhang B, Shan G, Li X.
    Eur J Surg Oncol; 2016 Jan; 42(1):81-6. PubMed ID: 26615455
    [Abstract] [Full Text] [Related]

  • 26. Predictive Factors of Superior Mediastinal Nodal Metastasis from Papillary Thyroid Carcinoma--A Prospective Observational Study.
    Woo JH, Park KN, Lee JY, Lee SW.
    PLoS One; 2016 Jan; 11(2):e0148420. PubMed ID: 26848952
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
    Li ZJ, An CM, Yan DG, Zhang XW, Zhang ZM, Xu ZG, Tang PZ.
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
    [Abstract] [Full Text] [Related]

  • 30. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ, Yoon JH, Han JM, Yim JH, Hong SJ, Song DE, Ryu JS, Kim TY, Shong YK, Kim WB.
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [Abstract] [Full Text] [Related]

  • 31. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH, Kuo SF, Hsueh C, Chao TC, Lin JD.
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [Abstract] [Full Text] [Related]

  • 32. [Clinical analysis of level V occult metastasis of papillary thyroid carcinoma].
    Zhang LY, Zhou X, Wu YS, Zhang L.
    Zhonghua Wai Ke Za Zhi; 2011 Jul 01; 49(7):611-4. PubMed ID: 22041675
    [Abstract] [Full Text] [Related]

  • 33. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.
    Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P, Barbieri V.
    Thyroid; 2012 Sep 01; 22(9):911-7. PubMed ID: 22827494
    [Abstract] [Full Text] [Related]

  • 34. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis.
    Roh JL, Kim JM, Park CI.
    Ann Surg Oncol; 2008 Sep 01; 15(9):2482-6. PubMed ID: 18612697
    [Abstract] [Full Text] [Related]

  • 35. Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study.
    Eweida AM, Sakr MF, Hamza Y, Khalil MR, Gabr E, Koraitim T, Al-Wagih HF, Abo-Elwafa W, Ezzat Abdel-Aziz T, Diab AA, El-Sabaa B, Nabawi AS.
    Eur Arch Otorhinolaryngol; 2017 Apr 01; 274(4):1951-1958. PubMed ID: 27999997
    [Abstract] [Full Text] [Related]

  • 36. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW, Yang XH, Wu BQ, Sun DL, Jiang Y, Qu Z.
    Clin Transl Oncol; 2019 Nov 01; 21(11):1482-1491. PubMed ID: 30879178
    [Abstract] [Full Text] [Related]

  • 37. Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus.
    Song CM, Lee DW, Ji YB, Jeong JH, Park JH, Tae K.
    Head Neck; 2016 Apr 01; 38 Suppl 1():E412-6. PubMed ID: 25581039
    [Abstract] [Full Text] [Related]

  • 38. [Preliminary study of patterns of level IIb lymph node metastasis in papillary thyroid carcinoma].
    Wan H, Zhang B, Liu S, Li Z, Wu Y, Wang X, Xu Z, Tang P.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan 01; 49(1):27-30. PubMed ID: 24680333
    [Abstract] [Full Text] [Related]

  • 39. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.
    Sessa L, Lombardi CP, De Crea C, Tempera SE, Bellantone R, Raffaelli M.
    World J Surg; 2018 Mar 01; 42(3):623-629. PubMed ID: 29238850
    [Abstract] [Full Text] [Related]

  • 40. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
    Ryu YJ, Kang SJ, Cho JS, Yoon JH, Park MH.
    Medicine (Baltimore); 2018 Dec 01; 97(51):e13435. PubMed ID: 30572443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.